Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
0.8113
-0.0711 (-8.06%)
At close: Aug 14, 2026, 4:00 PM EDT
0.7930
-0.0183 (-2.26%)
After-hours: Aug 14, 2026, 7:33 PM EDT
Onconetix Market Cap
Onconetix has a market cap or net worth of $2.99 million as of August 14, 2026. Its market cap has increased by 85.13% in one year.
Market Cap
2.99M
Enterprise Value
-2.76M
1-Year Change
85.13%
Ranking
Category
Stock Price
$0.81
ChartMarket Cap Chart
Since the IPO on February 18, 2022, Onconetix's market cap has decreased from $624.51M to $2.99M, a decrease of -99.52%. That is a compound annual growth rate of -69.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 2.99M | 23.46% |
| Dec 31, 2025 | 2.43M | -53.56% |
| Dec 31, 2024 | 5.22M | 43.70% |
| Dec 29, 2023 | 3.64M | -78.64% |
| Dec 30, 2022 | 17.02M | -97.28% |
| Feb 18, 2022 | 624.51M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SciSparc | 3.83M |
| TransCode Therapeutics | 3.68M |
| Curis | 3.64M |
| Galmed Pharmaceuticals | 3.50M |
| HCW Biologics | 3.49M |
| Jupiter Neurosciences | 3.47M |
| 60 Degrees Pharmaceuticals | 3.14M |
| GRI Bio | 3.13M |